Accelerate clinical trial coordination with an API-led strategy

COVID-19 has placed a significant emphasis on the safety and efficiency of clinical trials for life-saving vaccines and therapies. However, clinical trials represent one of the most significant expenses for life sciences organizations, and most trial operations are manual and disconnected. In response, pharmaceutical companies have accelerated their adoption of digital technologies to survive a global pandemic and spur innovation in response to the expectations placed on their industry.

Join us to see how MuleSoft is partnering with the world’s leading pharmaceutical organizations, like IQVIA, to accelerate decentralized clinical trials in an unpredictable and ever-changing landscape. Learn how to: 

  • Automate manual processes and scale enterprise-wide automation 
  • Provide comprehensive, real-time insights to trial stakeholders 
  • Drive collaboration across various investigators and CROs 
  • Orchestrate a patient-centric clinical trials platform

    By submitting this form, you agree to have your contact information, including email, passed on to Salesforce for the purpose of following up on your interests.

    All information that you supply is protected by our Privacy Policy.
    In order to provide you with this free service, we may share your business information with companies whose content you choose to view on this website.
    By submitting your information you agree to our Terms of Use.
    Third party cookies may be placed, to serve more relevant ads when you browse the web.
    You can learn more about those ads here.